RHEUMATOID PATIENTS AFTER FIVE OR MORE YEARS OF CORTICOSTEROID TREATMENT: A COMPARATIVE ANALYSIS OF 183 CASES

Abstract

Article1 May 1961RHEUMATOID PATIENTS AFTER FIVE OR MORE YEARS OF CORTICOSTEROID TREATMENT: A COMPARATIVE ANALYSIS OF 183 CASESCARL A. BERNTSEN, M.D., F.A.C.P., RICHARD H. FREYBERG, M.D., F.A.C.P.CARL A. BERNTSEN, M.D., F.A.C.P.Search for more papers by this author, RICHARD H. FREYBERG, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-54-5-938 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThis report summarizes the status of 183 patients with rheumatoid arthritis after a period of continuous corticosteroid treatment for five years or longer.The treatment program always included increased rest, appropriate physical measures, therapeutic exercises, adequate diet, and analgesics. Of these 183 patients there were 47 for whom corticosteroid was the only additional treatment; in the remaining 136 patients corticosteroids were used after gold salts had been discontinued because they were either ineffectual or were not tolerated, so the gold therapy did not influence the course of illness.Of these 183 patients 77% were females. At the end of observation...Bibliography1. BolletBunim AJJJ: The importance of serial joint x-rays in the evaluation of treatment of rheumatoid arthritis. Med. Clin. N. Amer. 39: (March) 439, 1955. CrossrefGoogle Scholar2. Ragan C: Rheumatoid arthritis; the natural history of the disease and its management. Bull. N. Y. Acad. Med. 27: 63, 1951. MedlineGoogle Scholar3. ShortBauerReynolds CLWWE: Rheumatoid arthritis. Harvard University Press, Cambridge, Mass., 1957. CrossrefGoogle Scholar4. DuthieBrownKnoxThompson JJPEJDM: Course and prognosis on rheumatoid arthritis. Ann. Rheum. Dis. 16: 411, 1957. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: New York, N. Y.*Received for publication April 29, 1960.From the Department of Medicine, The New York Hospital-Cornell Medical Center, and The Hospital for Special Surgery, New York, N. Y.†This study was supported in part by a grant from the National Institute of Arthritis and Metabolic Diseases, National Institutes of Health, Bethesda, Maryland.Requests for reprints should be addressed to Carl A. Berntsen, M.D., F.A.C.P., 449 East 68th St., New York, N. Y. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byDetermination of widely used non-steroidal anti-inflammatory drugs in biological fluids using simultaneous derivatization and air-assisted liquid–liquid microextraction followed by gas chromatography–flame ionization detectionSystemic glucocorticoids in rheumatologyDetermination of non-steroidal anti-inflammatory drugs in urine by hollow-fiber liquid membrane-protected solid-phase microextraction based on sol–gel fiber coatingSystemic glucocorticoids in rheumatologyModerate-term, low-dose corticosteroids for rheumatoid arthritisThe cost of glucocorticoid-associated adverse events in rheumatoid arthritisGlucocorticoids and rheumatoid arthritis: Back to the future?Glucocorticoid use in rheumatoid arthritisSYSTEMIC LOW-DOSE GLUCOCORTICOID TREATMENT IN RHEUMATOID ARTHRITISSystemic glucocorticoids in chronic arthritisThe incidence of cancer associated with the treatmentof rheumatoid arthritisLow-dose corticosteroid therapy in rheumatoid arthritis: Balancing the evidenceSimultaneous analysis of several non-steroidal anti-inflammatory drugs in human urine by high-performance liquid chromatography with normal solid-phase extractionLow-dose corticosteroids in rheumatoid arthritis. A meta-analysis of their moderate-term effectivenessThe Effect of Glucocorticoids on Joint Destruction in Rheumatoid ArthritisSHOULD STEROIDS BE USED IN THE MANAGEMENT OF RHEUMATOID ARTHRITIS?Rheumatic DisordersPrediction of the clinical efficacy of and intolerance to antirheumatic drug therapyCorticosteroid therapy in rheumatoid arthritisRheumatoid Arthritis: Current Concepts and Management, Part 2Corticosteroids in rheumatoid arthritisOral steroids in rheumatoid arthritisRare adverse reactions to non-steroidal anti-inflammatory drugsIs atherosclerosis a complication of long-term corticosteroid treatment?Adverse reactions to nonsteroidal anti-inflammatory drugs diclofenac compared with other nonsteroidal anti-inflammatory drugsCorticosteroids in rheumatoid arthritis: is a trial of their 'disease modifying' potential feasible?Long-Term Efficacy and Safety of Tolmetin Sodium in Treatment of Geriatric Patients with Rheumatoid Arthritis and Osteoarthritis: A Retrospective StudyMedikamentöse TherapieKlinisches Bild der nichtatopischen AtemwegsobstruktionThe Diagnosis and Management of Rheumatoid SynovitisConduction system in systemic lupus erythematosus with atrioventricular blockNeurologic Complications of Corticosteroid TherapySome Inflammatory Diseases in Man and Their Current TherapyResponse of “acute phase” globulins in different models of inflammation in ratsGLUCOCORTICOIDS IN RHEUMATIC FEVER AND RHEUMATOID ARTHRITISA CRITICAL APPRAISAL OF THERAPY IN RHEUMATOID ARTHRITISCorticosteroids and peptic ulcer: Is there a relationship?The link between norethynodrel and thromboembolismThe Endocrine System and the StomachLong-term Treatment with Corticosteroids in Rheumatoid Arthritis: (Over a Period of 9 to 12 Years)Recent developments in rheumatoid arthritis and related diseases 1 May 1961Volume 54, Issue 5Page: 938-953KeywordsAnalgesicsArthritisCorticosteroid therapyHospital medicineMetabolic disordersRheumatoid arthritisRisk managementSaltsSurgeryUlcers ePublished: 1 December 2008 Issue Published: 1 May 1961 PDF downloadLoading ...